Ozempic and Tarpeyo drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ozempic (semaglutide) and Tarpeyo (budesonide). Common drug interactions include dizziness among females and muscle spasms among males.

The phase IV clinical study analyzes what interactions people have when they take Ozempic and Tarpeyo. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Ozempic?

Ozempic has active ingredients of semaglutide. It is often used in weight loss. eHealthMe is studying from 29,761 Ozempic users. Check the latest studies of Ozempic.

What is Tarpeyo?

Tarpeyo has active ingredients of budesonide. eHealthMe is studying from 2,758 Tarpeyo users. Check the latest studies of Tarpeyo.



On Jul, 21, 2026

21 people who take Ozempic and Tarpeyo together, and have interactions are studied.

Ozempic and Tarpeyo drug interactions.

What are the common drug interactions of Ozempic and Tarpeyo, by gender? *:

female:

  1. Dizziness
  2. Nausea (feeling of having an urge to vomit)
  3. Lipohypertrophy (a lump under the skin caused by accumulation of extra fat at the site of many subcutaneous injections of insulin)
  4. Tremor (trembling or shaking movements in one or more parts of your body)
  5. Alopecia (absence of hair from areas of the body)
  6. Blood potassium increased
  7. Constipation
  8. Contusion (a type of hematoma of tissue in which capillaries)
  9. Fatigue (feeling of tiredness)
  10. Headache (pain in head)

male:

  1. Muscle spasms (muscle contraction)
  2. Oedema peripheral (superficial swelling)
  3. Medial tibial stress syndrome (pain in medial part of tibia)
  4. Proteinuria (presence of protein in the urine)
  5. Skin atrophy (wasting of skin)
  6. Vomiting
  7. Weight increased
  8. Autoimmune disorder (a condition in which the immune system attacks the body's normal substances and tissue)
  9. Diarrhoea
  10. Dyspepsia (indigestion)

What are the common drug interactions of Ozempic and Tarpeyo, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Dizziness
  2. Lipohypertrophy (a lump under the skin caused by accumulation of extra fat at the site of many subcutaneous injections of insulin)
  3. Tremor (trembling or shaking movements in one or more parts of your body)
  4. Nausea (feeling of having an urge to vomit)

30-39:

  1. Blood potassium increased
  2. Contusion (a type of hematoma of tissue in which capillaries)
  3. Renal impairment (severely reduced kidney function)

40-49:

  1. Pharyngitis streptococcal (inflammation of the pharynx caused by infection from. streptococcus)
  2. Constipation
  3. Fatigue (feeling of tiredness)
  4. Hypertension (high blood pressure)
  5. Impaired healing
  6. Nasopharyngitis (inflammation of the nasopharynx)
  7. Skin lesion
  8. Sluggishness (lacking alertness)

50-59:

  1. Blood creatinine increased
  2. Blood phosphorus increased
  3. Glomerular filtration rate decreased
  4. Abdominal distension
  5. Cushingoid (obesity and weakening of the muscles)
  6. Headache (pain in head)
  7. Proteinuria (presence of protein in the urine)
  8. Skin atrophy (wasting of skin)
  9. Vomiting
  10. Autoimmune disorder (a condition in which the immune system attacks the body's normal substances and tissue)

60+:

  1. Muscle spasms (muscle contraction)
  2. Oedema peripheral (superficial swelling)
  3. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  4. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
  5. Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
  6. Tendonitis (a condition that causes pain and swelling of tendons)
  7. Urinary incontinence (inability to control the flow of urine and involuntary urination)
  8. Weight increased
  9. Blood pressure increased
  10. Dehydration (dryness resulting from the removal of water)

What are the existing conditions these people have? *

  1. Iga Nephropathy (kidney disease- condition prevents the kidneys from filtering waste): 19 people, 90.48%

* Approximation only. Some reports may have incomplete information.

Do you take Ozempic and Tarpeyo?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ozempic and Tarpeyo:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ozempic:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Tarpeyo:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ozempic and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tarpeyo and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on semaglutide and budesonide (the active ingredients of Ozempic and Tarpeyo, respectively), and Ozempic and Tarpeyo (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: